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Endovascular repair of an abdominal aortic aneurysm (AAA) is an evolving technology
which continues to be practiced in more and more centres worldwide in an effort to avoid
major abdominal surgery and its associated morbidity and mortality. As with conventional
open surgery, the objective of endovascular management is to provide a durable repair
maintaining antegrade flow in the graft whilst simultaneously excluding flow in the aneu-
rysm. Endovascular treatment offers a less invasive alternative to standard surgical repair
with the potential of reduced hospitalisation, morbidity and mortality.
ª 2008 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction repair and watchful waiting (encompassing regular ultrasonicThe natural history of an abdominal aortic aneurysm (AAA) is
progressive enlargement until the aortic wall is so weakened
that it ruptures causing internal haemorrhaging. Most centres
report mortality rates from ruptured AAA’s of around 50%
(ranging from 32 to 70%).1–4 However, the overall mortality,
once rupture has occurred, approaches 90%.1,3 Therefore,
the primary objective in the treatment of a diagnosed AAA is
to prevent death from rupture which is the 3rd most common
cause of sudden death in theU.K. after coronary artery disease
and stroke.
Once an asymptomatic AAA is found, the most important
question becomes the probability of rupture. This probability
correlates well with the size of the aneurysm at initial detec-
tion (usually ultrasound) and is directly related to the aneur-
ysm’s diameter. Rupture rates are typically 25–40% at 5 years
for aneurysms greater than 5 cm in diameter, 5–7% for those
3.5–5.0 cm, and approach 0% for aneurysms less than 3.5 cm.5
The management options for an unruptured abdominal
aortic aneurysm previously included conventional ‘open’al Associates Ltd. Publishsurveillance and optimisation of medical risk factors). Stan-
dard surgical repair, involving a large abdominal incision
and cross-clamping of the aorta, is frequently complicated
by the high likelihood of associated comorbidities and has
an average mortality of approximately 2% increasing to 6%
in higher risk patients.6 With an ageing population, the num-
ber of high risk cases also increases. Average blood loss is 2–3
units in 95% of cases with an average hospital stay of 6 days.5,6
In recent years, a new minimally invasive technique, endo-
vascular aneurysm repair (EVAR), has been developed and in-
corporated into the management options for the elective
repair of an infrarenal AAA as an alternative to conventional
surgery.2. Endovascular aneurysm repair (EVAR)
EVAR was invented in the early 1990s by surgeons in the
Ukraine and Argentina as a less invasive method of AAAed by Elsevier Ltd. All rights reserved.
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technology have led EVAR to be used worldwide.
Endovascular aneurysm repair involves the transfemoral or
transiliac placement of an endograft within the aneurysm via
two small incisions made in the patient’s groin. The aim being
thecompleteexclusionof theaneurysmsac fromthecirculation.
Theendograft is anchored inplace by self-expandingor balloon-
expandable stents, whichmay support all or part of the graft.
Endovascular grafts fall into three broad categories:
(i) bifurcated or tubular unibody grafts
(ii) modular multicomponent grafts
(iii) aorto unilateral grafts with a contralateral iliac occluder
which are followed by surgical femoro-femoral bypass72.1. Anatomical suitability
The eligibility of a patient with an infrarenal AAA for endovas-
cular repair relies on certain anatomical requirements for
complete aneurysm exclusion. Aneurysms that rupture are
associatedwith larger diameters than their intact counterparts.
It has been suggested that larger aneurysmshavemore adverse
morphological featureswhichmay increase the technical diffi-
culty and therefore reduce theapplicability of the endovascular
technique. Several authors, however, have reported the appli-
cability of EVAR in approximately 60% of AAA’s.8–10
Contrast-enhanced spiral CT has become the investigation
of choice in the assessment of elective AAA for EVAR.11 Occa-
sionally, angiography is also used. Generally speaking, the an-
atomical determinations which must be made in planning
graft implantation are:
- diameter and length of the infrarenal aorta and neck of the
aorta
- diameter and length of the iliac attachments (‘landing zones’)
- tortuosity and size of the access vessels
- critical vessel anatomyCriteria of eligibility for EVAR
- Neck length 15 mm
- Neck diameter< 30 mm
- Neck angulation< 60–80
- Iliac diameter 7 mm2.2. Advantages of EVAR
Certain problems associated with conventional open repair of
AAA, and thus contributing to morbidity and mortality, that
are avoided by EVAR include the following:
- Open repair requires general anaesthetic
- Laparotomy, third space fluid losses, ileus, postoperative
ventilatory impairment, urinary retention, delayedmobility,
prolonged hospitalisation- Dissection of the aortic neckmay cause damage to the renal,
adrenal, lumbar and gonadal veins
- Aortic cross-clamping increases cardiac stress with
increased cardiac afterload. It also leads to visceral and renal
ischaemia (after suprarenal clamping), and lower limb is-
chaemia with the systemic complications of ischaemia-
reperfusion injury
Two recent randomised trials12,13 have reported a two-
thirds reduction in the 30-day mortality rate with elective
EVAR compared with conventional open surgery (1.6% and
1.2% for EVAR compared with 4.6% and 6% for open repair).2.3. Complications of EVAR
EVAR is not without its complications and these differ sub-
stantially from those encountered with open repair. The
majority of complications are related to the procedure itself.
Early complications (<30 days) include:
- wound complications: infection, haematomas, lympho-
celes
- arterial access complications: arterial perforation, rupture,
dissection and plaque embolisation, pseudoaneurysm
formation
- renal ostia coverage
- hypogastric artery embolisation complications: buttock
claudication, gluteal myonecrosis and renal failure
- endoleaks
- endograft limb occlusion/thrombosis
- systemic complications: despite EVAR resulting in fewer
systemic complications than open surgical repair, these
complications still represent the most frequent complica-
tion in the post-procedure period. The range of complica-
tions includes cardiac and pulmonary dysfunction, renal
failure, embolic phenomena and spinal cord ischaemia
Late complications: these are typically diagnosed on imag-
ing studies for graft surveillance. The common routine is a CT
scan at 1, 6 and 12 months post-procedure, and annually
thereafter. Late complications include:
- wound complications: lymphoceles and pseudoan-eurysms
- endoleaks
- endograft limb occlusion/thrombosis
- graft migration
- neck dilatation
- sac expansion
- endotension: defined as an increase in sac pressure without
the presence of an endoleak
- graft infection
- aortoduodenal fistula
- implant-related complications: hook fractures, modular
component separation and fabric erosion
- systemic complications: very few occur in the late period.
The surveillance regimen of serial CT scans with intrave-
nous contrast can, in certain patients, lead to contrast-
induced nephropathy
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A problem unique to EVAR is endoleaks which describe ‘‘the
inability to obtain ormaintain a secure seal between the aortic
wall and a transluminally implanted intra-aneurysmal
graft’’.14 In essence, endoleaks are the presence of flow out-
side the lumen of the endograft but within the aneurysm
sac. They increase the risk of aneurysm rupture and are the
primary reason for such close surveillance following the pro-
cedure. The rate of endoleak following endovascular repair
of AAA is approximately 14%.15 There are four types; Type I
– anastomotic at the attachment sites; Type II – collateral
back bleeding into the aneurysm sac; Type III – modular disso-
ciation; Type IV – graft material porosity. Each type of endo-
leak can be noted during the procedure or surveillance
period and all endoleaks may not be of equal significance.
Both Type I (attachment site) and Type III (modular limb
dislocation or graft fabric failure) are significant risk factors
for late aneurysm rupture.16 In contrast, Type II endoleaks
are generally considered as benign with only isolated cases
of aneurysm expansion and rupture.17 Type IV endoleaks
usually resolve spontaneously during the post-procedure
period.Classification of endoleaks
I Attachment site leaks
- Proximal end of endograft
- Distal end of endograft
- Iliac occluder (plug)
II Branch leaks (without attachment site connection)
- Simple or to-and-fro (from only one patent branch)
- Complex or flow-through (with two or more patent
branches)
III Graft defect
- Junctional leak or modular disconnection
- Fabric disruption (mid-graft hole)
Minor (<2 mm, e.g. suture holes)
Major (2 mm)
IV Graft wall (fabric) porosity (<30 days after graft placement)3. Conclusion
Since Parodi undertook the first endograft repair of an AAA in
1990, there has been great excitement.18 The new treatment
and technologies created much optimism and anticipation
which must now be tempered by clinical experience and
practical considerations. EVAR is currently constrained by
both technical limitations and patient selection criteria and
consequently, is not applicable to many patients with AAA.
EVAR requires significant commitments from the participat-
ing physicians and the facilities in both time and logistical
support. The promise of decreasing mortalities and short-
ened hospital stays are countered by the extremely highcost of devices and the application of aneurysm repair to
a higher risk patient population. Large delivery catheters ex-
clude many women whose small iliac arteries will not ac-
commodate such devices.
EVAR is an exciting but demanding technology which
holds great promise. The hope for the future is less costly,
smaller profile devices with wider applicability, improved sta-
bility and fixation, and the elimination of endoleaks providing
a durable repair comparable to a surgical graft. Continued
research and development are needed in order to make
EVAR an exclusively percutaneous procedure and attain these
goals, thus improving patient care.
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